RIQAS - CYFRA 21-1 EQA
The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of CYFRA 21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.
- Lyophilised samples
- Monthly reporting
- Testing covers the full range of clinically relevant decision levels
Monthly reporting
- Submit results and view reports online via RIQAS.net
- 12 month subscription
-
RIQAS
- Randox
-
CYFRA 21-1 EQA
